Skip to main content

Christopher G. Hayes

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Christopher G. Hayes

Verrica Pharmaceuticals Inc. reported in an 8-K filed April 25, 2025 that Christopher G. Hayes resigned as Chief Legal Officer, Chief Compliance Officer and Corporate Secretary, effective April 30, 2025. The proxy statement of Verrica Pharmaceuticals Inc. reports total compensation of $747,579 for Christopher G. Hayes in fiscal 2025, including a base salary of $155,333. Disclosed compensation is on record for 3 fiscal years.

“On April 22, 2025, Christopher G. Hayes notified Verrica Pharmaceuticals Inc. (the "Company") that he will resign from his positions as the Company's Chief Legal Officer, Chief Compliance Officer and Corporate Secretary effective as of April 30, 2025 (the "Separation Date") (such resignation, the "Hayes Resignation").”
Verrica Pharmaceuticals Inc. Form 8-K, filed April 25, 2025 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Verrica Pharmaceuticals Inc. (VRCA) $155,333 $747,579
2024 Verrica Pharmaceuticals Inc. (VRCA) $466,000 $1,028,062
2023 Verrica Pharmaceuticals Inc. (VRCA) $424,000 $2,561,674

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.